Show simple item record

Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis : results from a UK national register

dc.contributor.authorMacfarlane, Gary J
dc.contributor.authorMacDonald, Ross I R
dc.contributor.authorPathan, Ejaz
dc.contributor.authorSiebert, Stefan
dc.contributor.authorGaffney, Karl
dc.contributor.authorChoy, Ernest
dc.contributor.authorPackham, Jon
dc.contributor.authorMartin, Kathryn R
dc.contributor.authorHaywood, Kirstie
dc.contributor.authorSengupta, Raj
dc.contributor.authorAtzeni, Fabiola
dc.contributor.authorJones, Gareth T
dc.date.accessioned2018-07-24T11:05:08Z
dc.date.available2018-07-24T11:05:08Z
dc.date.issued2018-11-01
dc.identifier129927525
dc.identifier4c6013da-054d-406c-b02c-196c51951c5b
dc.identifier85055598135
dc.identifier.citationMacfarlane , G J , MacDonald , R I R , Pathan , E , Siebert , S , Gaffney , K , Choy , E , Packham , J , Martin , K R , Haywood , K , Sengupta , R , Atzeni , F & Jones , G T 2018 , ' Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis : results from a UK national register ' , Rheumatology , vol. 57 , no. 11 , pp. 1982-1990 . https://doi.org/10.1093/rheumatology/key206en
dc.identifier.issn1462-0324
dc.identifier.otherRIS: urn:031119A450CAB072AAE972126922D4D4
dc.identifier.otherRIS: urn:031119A450CAB072AAE972126922D4D4
dc.identifier.otherORCID: /0000-0003-4539-7147/work/52310230
dc.identifier.otherORCID: /0000-0003-2322-3314/work/72631710
dc.identifier.otherORCID: /0000-0003-0016-7591/work/83703966
dc.identifier.urihttp://hdl.handle.net/2164/10790
dc.descriptionFunding: This work was supported by Arthritis Research UK (grant 21378) conducted as part of the Fibromyalgia Optimal Management in Axial Spondyloarthritis study.en
dc.format.extent8
dc.format.extent218075
dc.language.isoeng
dc.relation.ispartofRheumatologyen
dc.subjectaxial spondyloarthritisen
dc.subjectbiologic therapyen
dc.subjectcohort studyen
dc.subjectco-morbidityen
dc.subjectdisease activityen
dc.subjectdisease registeren
dc.subjectepidemiologyen
dc.subjectfibromyalgiaen
dc.subjectoutcomeen
dc.subjectresponseen
dc.subjectR Medicineen
dc.subjectArthritis Research UK (ARUK)en
dc.subject21378en
dc.subject.lccRen
dc.titleInfluence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis : results from a UK national registeren
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Vice Principalsen
dc.contributor.institutionUniversity of Aberdeen.Epidemiology Groupen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH)en
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Natural & Computing Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.description.statusPeer revieweden
dc.identifier.doi10.1093/rheumatology/key206


Files in this item

Thumbnail
Name:
Influence_of_co_morbid_fibromy ...
Size:
212.9Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record